International Journal of Surgical Oncology

Scope & Guideline

Elevating standards in cancer treatment and surgery.

Introduction

Explore the comprehensive scope of International Journal of Surgical Oncology through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore International Journal of Surgical Oncology in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN2090-1402
PublisherHINDAWI LTD
Support Open AccessYes
CountryUnited States
TypeJournal
Convergefrom 2012 to 2024
AbbreviationINT J SURG ONCOL / Int. J. Surg. Oncol.
Frequency-
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON W1T 5HF, ENGLAND

Aims and Scopes

The International Journal of Surgical Oncology focuses on advancing the understanding and treatment of surgical oncology through rigorous research. It aims to publish high-quality studies that contribute to the field's knowledge base, particularly in surgical techniques, cancer biology, and patient outcomes.
  1. Surgical Techniques and Innovations:
    The journal emphasizes research on novel surgical techniques and innovations in oncology, exploring their efficacy and safety in treating various cancers.
  2. Cancer Prognosis and Risk Factors:
    A core focus is on identifying prognostic factors and risk factors associated with different cancers, which aids in better patient stratification and management.
  3. Translational Research in Oncology:
    The journal publishes studies that bridge laboratory research and clinical applications, particularly those that investigate biomarkers and treatment responses.
  4. Cost-Effectiveness and Quality of Life Assessments:
    Research on the economic impact of surgical interventions and their effects on patients' quality of life is also a significant area of interest.
  5. Multidisciplinary Approaches in Cancer Treatment:
    The journal encourages studies that showcase the benefits of multidisciplinary approaches to cancer treatment, integrating surgery with other modalities such as chemotherapy and radiotherapy.
Recent publications in the International Journal of Surgical Oncology reveal emerging themes and trends that indicate the evolving landscape of surgical oncology research. These trends reflect the journal's responsiveness to contemporary challenges and advancements in the field.
  1. Immunotherapy and Targeted Therapies:
    There is a growing body of research focused on the integration of immunotherapy and targeted therapies in surgical oncology, highlighting their roles in improving patient outcomes.
  2. Patient-Centered Outcomes and Quality of Life:
    Increasing emphasis on studies that assess patient-reported outcomes and quality of life after surgical interventions indicates a trend towards more holistic approaches to cancer care.
  3. Innovative Imaging Techniques in Surgery:
    Research exploring the use of advanced imaging techniques, such as intraoperative ultrasound and PET/CT planning, is on the rise, reflecting the need for precision in surgical oncology.
  4. Analysis of Complications and Morbidity:
    A trend toward identifying and analyzing postoperative complications and morbidity rates emphasizes the importance of improving surgical safety and patient care.
  5. Epidemiological Studies with Clinical Relevance:
    Emerging studies focus on epidemiological trends that directly inform clinical practices, especially those that relate to specific patient populations and their unique challenges.

Declining or Waning

While the journal maintains a strong focus on various aspects of surgical oncology, certain themes have shown a decline in publication frequency or relevance over recent years. This may reflect shifting research priorities or advancements in the field.
  1. Traditional Surgical Techniques:
    There is a noticeable decrease in studies focusing on conventional surgical methods, likely due to the growing interest in minimally invasive techniques and robotic surgery.
  2. Basic Epidemiological Studies:
    Research that solely examines epidemiological data without a strong connection to surgical practice or outcomes appears to be waning, as the journal seeks more clinically relevant studies.
  3. Single-Center Studies with Limited Scope:
    The trend towards publishing multicenter studies or those with broader implications is reducing the acceptance of single-center studies, which may not provide enough generalizability.

Similar Journals

Molecular and Clinical Oncology

Uncovering the molecular secrets of oncology.
Publisher: SPANDIDOS PUBL LTDISSN: 2049-9450Frequency: 12 issues/year

Molecular and Clinical Oncology is a dynamic journal published by SPANDIDOS PUBL LTD, aimed at advancing the understanding of cancer biology and treatment modalities. With an ISSN of 2049-9450 and an E-ISSN of 2049-9469, the journal serves as a critical platform for researchers and clinicians dedicated to uncovering novel insights in molecular oncology and enhancing clinical practices. As a testament to its growing influence, the journal has achieved a Q3 ranking in Oncology and a Q4 ranking in Cancer Research for the year 2023, reflecting its commitment to publishing high-quality research. Although currently not an Open Access publication, the journal offers crucial subscription options, ensuring comprehensive access to groundbreaking studies and innovations in the field. With converged years spanning 2018 to 2024, the journal is set to continue enriching the academic community with its valuable contributions, ultimately empowering researchers, professionals, and students engaged in the fight against cancer.

Breast Cancer

Innovating treatment strategies for better patient outcomes.
Publisher: SPRINGER JAPAN KKISSN: 1340-6868Frequency: 6 issues/year

Breast Cancer is a prestigious peer-reviewed journal published by SPRINGER JAPAN KK, specializing in the multifaceted domains of oncology and medical pharmacology. With an impressive impact factor and recognized within the Q1 category in multiple areas, including Medicine (miscellaneous), Radiology, and Nuclear Medicine and Imaging, this journal serves as a fundamental resource for cutting-edge research and clinical advancements in breast cancer treatment and care. Its indexed presence in renowned databases like Scopus further affirms its significance, ranking 56th in Radiology and 60th in Pharmacology. The journal aims to bridge the gap between clinical practice and scientific research by publishing original articles, reviews, and case studies that enhance understanding and improve patient outcomes. With converged content available from 1994 to 2024, the journal is dedicated to fostering innovative research while engaging a global audience of researchers, clinicians, and students passionate about tackling breast cancer challenges.

IN VIVO

Advancing cancer research through innovative insights.
Publisher: INT INST ANTICANCER RESEARCHISSN: 0258-851XFrequency: 6 issues/year

IN VIVO is a prestigious academic journal published by the International Institute of Anticancer Research, dedicated to advancing the fields of biochemistry, genetics, molecular biology, cancer research, and pharmacology. With its ISSN 0258-851X and E-ISSN 1791-7549, this journal has been a key contributor to innovative research since its inception in 1987, providing a crucial platform for the dissemination of significant findings in its scope. With an impressive impact reflected in its quartile rankings (Q2 in Biochemistry, Genetics and Molecular Biology and Medicine; Q3 in Cancer Research and Pharmacology), IN VIVO reaches a global audience comprising researchers, health professionals, and students. Although it operates on a subscription basis, the journal’s commitment to scientific excellence and rigorous peer review ensures that all published works maintain high quality and relevance. Notably positioned in Scopus ranks within the 36th to 59th percentiles across various categories, IN VIVO continues to be a vital resource for cutting-edge research and developments, solidifying its importance within the scientific community.

Actas Urologicas Espanolas

Elevating Standards in Urology Research
Publisher: ELSEVIER ESPANAISSN: 0210-4806Frequency: 10 issues/year

Actas Urologicas Espanolas is a prestigious journal published by Elsevier España, dedicated to the field of Urology. Established in 1977, this journal has significantly contributed to advancing knowledge and research in urological medicine and surgery, spanning a comprehensive scope that includes clinical studies, surgical techniques, and the latest innovations in the treatment of urological diseases. With an impact factor reflecting its critical role in the academic community, it is ranked Q3 in the Urology category as of 2023, placing it amongst the valuable resources for professionals and researchers. The journal is indexed under Scopus, achieving a commendable rank of #70 out of 120 in the Medicine-Urology category, situating it within the 42nd percentile. As a significant platform for sharing advancements and findings, it encourages submissions that enhance urological care and improve patient outcomes. Although not an Open Access journal, the publication remains vital for those looking to stay updated on the latest developments in urology. For more details, visit their office located at CALLE DE ZURBANO, 76-4TH FLR LEFT, MADRID, 28010, SPAIN.

Gynecologic Oncology

Pioneering Insights for Tomorrow's Gynecologic Care
Publisher: ACADEMIC PRESS INC ELSEVIER SCIENCEISSN: 0090-8258Frequency: 12 issues/year

Gynecologic Oncology, an esteemed journal published by Academic Press Inc Elsevier Science, stands at the forefront of research in the domains of Obstetrics and Gynecology and Oncology. With an exceptional track record dating from 1972 to 2024, this journal has established itself as a vital resource for scholars and practitioners alike, boasting a remarkable Q1 ranking in both fields as of 2023. Gynecologic Oncology not only ranks #13 out of 209 in Obstetrics and Gynecology and #72 out of 404 in Oncology but also operates within the top percentiles of academic influence, with a 94th percentile in Obstetrics and Gynecology and an 82nd percentile in Oncology on Scopus. Although the journal does not currently offer open access, it remains crucial for disseminating original research, reviews, and advances in the management and treatment of gynecological cancers. Researchers and health professionals will find this journal indispensable for staying informed on the latest advancements and breakthroughs in this vital area of medicine, fostering a deeper understanding and potentially transforming patient care practices.

Translational Lung Cancer Research

Advancing lung cancer research for a healthier tomorrow.
Publisher: AME PUBLISHING COMPANYISSN: 2218-6751Frequency: 6 issues/year

Translational Lung Cancer Research is a leading journal dedicated to advancing the field of oncology, particularly focusing on groundbreaking discoveries in lung cancer treatment and management. Published by AME Publishing Company, this journal boasts an impressive Q1 classification in the 2023 Oncology category, reflecting its significant contribution to the scientific community, with an outstanding Scopus rank of #92 out of 404 in Medicine _ Oncology, placing it in the 77th percentile. With its commitment to open access, the journal fosters international collaboration and accessibility, making cutting-edge research available to a wide audience. The scope of Translational Lung Cancer Research encompasses clinical trials, experimental studies, and translational research that bridge the gap between laboratory findings and clinical applications. Researchers, professionals, and students seeking to keep abreast of the latest developments in lung cancer research will find invaluable insights within its pages. For further information, please contact at FLAT-RM C 16F, KINGS WING PLAZA 1, NO 3 KWAN ST, SHATIN, HONG KONG.

JOURNAL OF SURGICAL ONCOLOGY

Fostering Breakthroughs in Surgical Oncology Practices
Publisher: WILEYISSN: 0022-4790Frequency: 16 issues/year

The JOURNAL OF SURGICAL ONCOLOGY, published by Wiley, stands as a pivotal resource for medical professionals, researchers, and students engaged in the fields of surgery and oncology. Established in 1969, this esteemed journal covers a diverse range of topics related to the surgical management of cancer, supporting advancements in treatment protocols and patient care. With a Q1 ranking in Surgery and Q2 rankings in both Medicine and Oncology for 2023, it holds a prominent position in the academic landscape, underscoring its impact in enhancing surgical techniques and oncological research. Researchers looking to disseminate their findings will benefit from the journal's rigorous peer-review process and commitment to publishing high-quality content that drives innovation in the field. For access, readers will find both print and online formats available, making vital research accessible to a broad audience committed to improving surgical oncology practice.

South Asian Journal of Cancer

Championing open access to vital cancer research.
Publisher: GEORG THIEME VERLAG KGISSN: 2278-330XFrequency: 4 issues/year

South Asian Journal of Cancer, published by GEORG THIEME VERLAG KG, is a pivotal platform for research in the fields of oncology and cancer research. Established in 2012 and operating under an Open Access model, this journal aims to disseminate high-quality, peer-reviewed articles that address crucial developments in cancer treatment, prevention, and research, particularly within the South Asian context. Despite its young history, the journal has been positioned within the Q4 quartile for both Cancer Research and Oncology, and while current Scopus rankings indicate it resides in the lower percentiles, its commitment to amplifying regional voices and research is invaluable. With its headquarters in Stuttgart, Germany, and a global readership, South Asian Journal of Cancer is dedicated to enhancing collaboration among researchers, healthcare professionals, and students, fostering a space for innovative ideas and advancements in cancer care as we progress through to 2024.

Indian Journal of Surgical Oncology

Transforming Surgical Oncology through Collaborative Discourse
Publisher: SPRINGER INDIAISSN: 0975-7651Frequency: 4 issues/year

The Indian Journal of Surgical Oncology, published by SPRINGER INDIA, is a vital source of scholarly research and discourse in the fields of oncology and surgery. Since its inception in 2010, the journal has been dedicated to advancing the science and practice of surgical oncology, providing a platform for researchers, clinicians, and educators to disseminate their findings and insights. With an increasing impact factor, the journal currently ranks in the Q4 category in Oncology and Q3 category in Surgery, reflecting its growing influence in the academic community. The journal maintains a focus on high-quality research, clinical studies, and innovative surgical techniques, fostering knowledge exchange among professionals in India and beyond. Although an open access option is not provided, the journal remains an essential repository of information for anyone engaged in the rapidly evolving fields of surgical oncology. For access to groundbreaking research and updates in the discipline, the Indian Journal of Surgical Oncology continues to be an indispensable resource.

International Journal of Surgery-Oncology

Exploring the Frontiers of Surgical Oncology for Better Health
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 2471-3864Frequency:

International Journal of Surgery-Oncology, published by Lippincott Williams & Wilkins, is a vital platform for the dissemination of high-quality research in the field of surgical oncology. With its dedicated focus on the intersection of surgery and cancer treatment, this journal aims to publish original research articles, reviews, and clinical studies that advance the understanding and management of oncological conditions through surgical techniques. Though currently not an open-access journal, the International Journal of Surgery-Oncology benefits from rigorous peer-review standards, ensuring that only the most impactful research reaches its audience of surgeons, oncologists, and healthcare professionals. Researchers and practitioners in the field can rely on this journal to stay updated with the latest innovations and clinical practices, ultimately aiming to improve patient outcomes in surgical oncology. Based in Philadelphia, this journal is set to play an instrumental role in shaping the future of cancer surgery.